Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |